Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
Keyword(s):
Phase 3
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 58
(10)
◽
pp. S236
Keyword(s):
Keyword(s):
2018 ◽
Vol 40
(12)
◽
pp. 2099-2111
◽
Keyword(s):
2018 ◽
Vol 26
(2)
◽
pp. 150-159
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol Volume 11
◽
pp. 275-281
Keyword(s):